Synthetic antibody treats congenital myasthenia in mice
Researchers have designed an antibody that attaches to MuSK, which prevented early lethality of mice with congenital myasthenia.
List view / Grid view
Researchers have designed an antibody that attaches to MuSK, which prevented early lethality of mice with congenital myasthenia.
Scientists have produced the first pathoconnectome - an open access map for other researchers that shows how eye disease can alter retinal circuitry.
New approach for testing for ALS may be useful to reverse debilitating disease...
PARP inhibitors show promise in preventing toxic accumulations of brain disease proteins in Penn research study...
A new Tel Aviv University study identifies a previously unknown mechanism involved in the development of Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS).
A study identifies a novel treatment strategy that preserved neuromuscular synapses in a mouse model of aggressive ALS...
Newly described stretches of super-silenced DNA reveal a fresh approach to reprogram cell identity.
Scientists may have found possible targets for therapeutic interventions in the fight against Lou Gehrig’s disease.
A new study shows that a variant in UBQLN4 gene has been associated with Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS). The study also describes how this gene variant disrupts a cellular process that drives motor neuron development. This new insight opens the door to potential treatment targets for…